Hyaluronic Acid
Partner with BD to support your combination drug product development needs for Hyaluronic Acid.
- Specialty In-clinic Drugs
- Addressing Your Needs
Hyaluronic Acid
Hyaluronic acid (HA) is a glycosaminoglycan with unique properties that make it a versatile therapy with a variety of clinical applications:1
- Derma l fillers - collagen stimulation, anti-aging, moisturizing.2
- Orthopedics - treatment of osteoarthritis.3
- Ophthalmology* - retinal detachment, dry eye treatment, and contact lenses hydration.4
- Nephrology - first line treatment for vesicoureteral reflux.5,*
One challenge of delivering hyaluronic acid is that due to its viscosity, hyaluronicacid exerts high pressure on the syringe.6 This pressure may cause the needle to come off, causing product leakage. This is an important consideration when selecting a delivery solution.
* BD Prefillable Syringes are not validated for any ophthalmic applications or vesicoureteral reflux.
BD Hylok™ Glass Prefillable Syringe for Hyaluronic Acid
BD: your partner in the development of your hyaluronic acid product
You require high quality prefillable syringes and an experienced support team to ensure that your hyaluronic acid combination product is safe and effective.
BD HylokTM Glass Prefillable Syringe for Hyaluronic Acid comes with a Luer Lock Adaptor (LLA) to support needle connection.7
So why choose BD as your combination product
development partner?
Choose BD to deliver your product to healthcare settings across the world, and you also choose BD industry-leading products, BD experience and BD expertise.
Choose BD to bring your drug to market
Backed by more than 60 years of experience, BD prefillable syringes
and services support medication delivery to benefit you, patients and clinicians
Explore our products
- Matthew Dovedytis, et al. Hyaluronic acid and its biomedical applications: A review - Engineered Regeneration - Volume 1, 2020, Pages 102-113
- Syed Nasir Abbas Bukhari, et al. Hyaluronic acid, a promising skin rejuvenating biomedicine: A review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects - International Journal of Biological Macromolecules - Volume 120, Part B, December 2018, Pages 1682-1695
- Fabio Ramos Costa, et al. Intra-Articular Hyaluronic Acid in Osteoarthritis and Tendinopathies: Molecular and Clinical Approaches - Biomedicines 2023, 11(4), 1061;
- Wan-Hsin Chang, et al. Applications of Hyaluronic Acid in Ophthalmology and Contact Lenses - Molecules. 2021 May; 26(9): 2485.doi: 10.3390/molecules26092485 - PMCID: PMC8123179 - PMID: 33923222
- Florian Friedmacher, et al. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results - J Urol.2018 Sep;200(3):650-655. doi: 10.1016/j.juro.2018.03.074. Epub 2018 Mar 15. PMID: 29551405 DOI: 10.1016/j.juro.2018.03.074
- Monheit, G. D., & Coleman, K. M. (2006). Hyaluronic acid fillers. Dermatologic therapy, 19(3), 141-150.
- BD Hylok™ IV connectors and needles compatibility [Internal Report]. Pont-de-Claix, Becton Dickinson and Company, 2016
- BDM-PS Financial file November 2022, "Actual FY22" Perimeter.